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Transposed elements affect transcriptomes <p>Analysis of transposed elements in the human and mouse genomes reveals many effects on the transcriptomes, including a higher level  of exonization of <it>Alu </it>elements than other elements.</p>
Abstract
Background: Transposed elements (TEs) have a substantial impact on mammalian evolution and
are involved in numerous genetic diseases. We compared the impact of TEs on the human
transcriptome and the mouse transcriptome.
Results: We compiled a dataset of all TEs in the human and mouse genomes, identifying 3,932,058
and 3,122,416 TEs, respectively. We than extracted TEs located within human and mouse genes
and, surprisingly, we found that 60% of TEs in both human and mouse are located in intronic
sequences, even though introns comprise only 24% of the human genome. All TE families in both
human and mouse can exonize. TE families that are shared between human and mouse exhibit the
same percentage of TE exonization in the two species, but the exonization level of Alu, a primate-
specific retroelement, is significantly greater than that of other TEs within the human genome,
leading to a higher level of TE exonization in human than in mouse (1,824 exons compared with
506 exons, respectively). We detected a primate-specific mechanism for intron gain, in which Alu
insertion into an exon creates a new intron located in the 3' untranslated region (termed
'intronization'). Finally, the insertion of TEs into the first and last exons of a gene is more frequent
in human than in mouse, leading to longer exons in human.
Conclusion: Our findings reveal many effects of TEs on these two transcriptomes. These effects
are substantially greater in human than in mouse, which is due to the presence of Alu elements in
human.
Background
The completion of the human and mouse genome draft
sequences confirmed that transposed elements (TEs) play a
major role in shaping mammalian genomes [1,2]. Transposed
elements comprise at least 45% of the human and 37% of the
mouse genomes. In the human genome, Alu is the most abun-
dant transposed element (TE), comprising more than one
million copies, which is about 10% of the genome. We
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previously reported that more than 5% of the alternatively
spliced internal exons in the human genome are derived from
Alu, and to the best of our knowledge all Alu-driven exons
originated from exonization of intronic sequences [3,4]. Alu
elements were shown to create alternative cassette exons,
whereas exonization of a constitutively spliced exon was
shown to have deleterious effects [4,5]. Alternatively spliced
Alu exons thus enrich the transcriptome, the coding capacity,
and the regulatory versatility of primate genomes with new
isoforms, without compromising the integrity and the origi-
nal repertoire of the transcriptome and its resulting pro-
teome. Therefore, exonization with low inclusion level is
thought to be the playground for future possible exaptation
(adopting a new function that is different from its original
one) [6] and fixation within the human transcriptome [3,7-
11].
Several indications imply that Alu insertions can add new
functionality to proteins, such as exon 8 of ADAR2 gene [12].
An analysis of protein databases indicates that mammalian
interspersed repeat (MIR) and CR1 (chicken repeat 1) TEs can
contribute to human protein diversification also [7]. Moreo-
ver, ultraconserved exons were found to originate from an old
short interspersed nuclear element (SINE) [13]. Another
important role for new exonizations is a potential tissue spe-
cificity, in which many minor form exons (which are mainly
new exonizations) exhibit strong tissue regulation [14].
Experimental support for this bioinformatics analysis is given
by a report of Alu de novo insertion and subsequent exoniza-
tion within the dystrophin, creating a tissue-specific exon that
results in cardiomyopathy [15]; Alu exonization within the
NARF gene was also shown to differ among human tissues
[16].
TEs are also thought to contribute to the turnover of intron
sequences, because there is often equilibrium between
sequence gain (by TEs) and sequence loss by unequal crossing
over between TEs [17]. Sironi and coworkers [18] identified
constraints on insertion of transposed elements within
introns, and they showed that gene function and expression
influence insertion and fixation of distinct transposon fami-
lies in mammalian introns [19].
The origin of spliceosomal introns is a longstanding unre-
solved mystery. It was recently demonstrated that the dupli-
cation of small genomic portions containing 'AGGT' provides
the boundaries for new introns [20]. In only two cases is the
origin of the intron known: a SINE insertion that gave rise to
a new intron in the coding region of the catalase A gene of
rice, and two midge globin genes that acquired an intron via
gene conversion with an intron-containing paralog [21,22]. It
has been postulated that humans underwent only intron loss
and not intron gain [23,24], and new introns that originated
from SINE insertion have not been reported in vertebrates.
In addition to Alu, the human genome contains multiple cop-
ies of other families of TEs, including MIR (a tRNA-derived
SINE) and long interspersed nuclear element (LINEs) such as
(LINE)-1 (L1), LINE-2 (L2), and CR1 (L3). The mouse
genome contains MIR elements as well as rodent-specific
SINEs, such as B1, which is a 7SL RNA-derived TE that origi-
nated from the same ancestral sequence as the left arm of the
Alu; B2, B4, and ID, which are tRNA-derived SINEs; and
LINEs such as L1, L2, and CR1. The human and mouse
genome also contain several copies of long terminal repeats
(LTRs) and DNA repetitive elements. The latter were recently
shown to be intensively active in the primate lineage [25]. The
mouse genome was chosen for comparative analysis of TE
insertions, because this genome contains a TE originating
from the same ancestral sequence of the Alu (B1) [26] in mul-
tiple copies, as well as the fact that complete annotations of
the genome are available, and there is a high coverage of the
mouse transcriptome by expressed sequence tags (ESTs) and
cDNAs.
In this work, we addressed several questions concerning the
global effect of TEs on the human transcriptome and whether
the exonization process is unique to primates or is shared by
other mammals as well. More specifically, we wished to
answer the following questions. Do all TE families exonize?
Do all TEs have the same exonization rate? Are some of these
newly created exons tissue-specific? Furthermore, inasmuch
as cancerous tissues have been shown to adopt aberrant splic-
ing patterns [27], are there TE exonizations that are poten-
tially cancer specific? Can we detect exonized TEs that are not
alternatively spliced? Are TE insertions responsible for the
origin of new introns within the human or mouse genome?
TEs are inserted into introns in sense and antisense orienta-
tions relative to the mRNA precursor. Hence, do exonized
TEs have a preferential orientation, and how many of them
contribute a whole exon? Do TEs enter into all parts of the
mRNA with the same probability? How many of these exoni-
zations potentially contribute to proteome diversity? And
finally, do they possess the same characteristics as conserved
alternatively spliced cassette exons?
To address these questions, we compiled a dataset of all SINE,
LINE, LTR, and DNA TEs in the human and mouse genome.
We analyzed insertions into introns and the effect of TE inser-
tions on the transcriptome. Our analysis indicates that TEs
have a greater effect on shaping the human transcriptome
than the mouse transcriptome. This effect is 3.6 times greater
in human than in mouse, and this is caused by a higher level
of exonization of the Alu element, which is a primate-specific
TE. Four lines of evidence support our finding. First, the
exonization level of Alu is significantly greater compared with
other TEs within the human transcriptome. Second, all TEs
within the mouse transcriptome have the same exonization
level. Third, TEs that belong to the same families, such as
MIR, LINE-2, and CR1, exonize in the same level in both spe-
cies. Finally, the level of TE exonization in human comparedhttp://genomebiology.com/2007/8/6/R127 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. R127.3
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Genome Biology 2007, 8:R127
with mouse is significantly greater after normalization for dif-
ferences in transcript coverage. Moreover, we found that Alu
insertion within exons in the human transcriptome, a process
termed 'intronization', creates a new alternative intron, which
is a primate-specific intron of the intron retention type.
Finally, these findings indicate that Alu elements play many
important roles in shaping human evolution, presumably
leading to a greater degree of transcriptomic complexity.
Results
Genome-wide survey of transcripts containing 
transposed elements
To evaluate the effect of TEs on the human and mouse tran-
scriptome, we calculated the total number of TEs in both
genomes, the number of TEs in introns, and the number of
TEs that are present within mRNA molecules. We therefore
downloaded EST and cDNA alignments, as well as repetitive
elements' annotations of the human genome and the mouse
genome from the University of California, Santa Cruz (UCSC)
genome browser (hg17 and mm6, respectively) [28], and ana-
lyzed for TE insertions (see Materials and methods, below).
Our analysis of the numbers of TEs in the human and mouse
genomes is summarized in Tables 1 and 2, respectively. There
are approximately 3.9 and 3.1 million copies of TEs in the
human and mouse genomes, respectively. The most abundant
TE families within the human genome are Alu and L1 ele-
ments, with almost 1.1 million and 800,000 copies each. The
most abundant TE families in the mouse genome are L1
(800,000 copies) and B1 (500,000 copies).
Next, we examined the number of TEs in introns. It is inter-
esting to note that all families of TEs have a tendency to reside
within intronic regions. Between 44% and 66% of TE inser-
tions are located within intronic sequences. Alu in humans
and B4 in mice have the highest ratio of insertions within
introns (66%), whereas L1 and LTR both in human and
mouse have the lowest percentage of copies within introns
(58% in human and 56% in mouse for L1, 44% in human and
52% in mouse for LTR). L1 and LTR exhibit a biased insertion
in the antisense orientation relative to the mRNA within
intronic sequences in both human and mouse: 185,428 and
96,718 L1 repeats were inserted in the antisense and sense
orientations in human, respectively; 113,862 and 68,101 L1
repeats in mouse; 96,654 and 39,804 LTRs in human; and
1 0 1 , 0 0 1  a n d  5 5 , 6 8 9  L T R s  i n  m o u s e .  N o  s u c h  b i a s  w a s
d e t e c t e d  i n  S I N E s ,  o r  i n  L 2 ,  C R 1 ,  a n d  D N A  r e p e a t s .  T h i s
shows a tendency toward insertion or fixation of all TEs into
intronic sequences.
Did all transposed elements families undergo 
exonization, and do they all have the same exonization 
level?
TEs present in EST/cDNA were separated into those that
were entered within annotated genes (according to the
knownGene list in UCSC; see Materials and methods, below)
and those that were not mapped to known genes. These were
considered non-protein-coding genes (see Materials and
methods, below).
We then examined exonization of TEs, that is, an internal
exon in which a TE is either as part of or as the entire exon
sequence. All TE families in both human and mouse can
undergo exonization (Tables 1 and 2, respectively; the two
right-most columns). We found a much higher level of TE
exonization in the human transcriptome than in the mouse
transcriptome. We calculated the exonization level (LE) as
the percentage of TEs that exonized within the number of
Table 1
TE effect on the human transcriptome
RE Total Intronic TE in introns of UCSC 
annotated genesa
TE in introns of non-
annotated genesa
TE exonization in UCSC 
annotated genesa
TE exonization in non-
annotated genesa
Alu 1,094,409 718,460 (66%) 480,052 238,408 1060 (0.2%) 584 (0.2%)
MIR 537,730 351,366 (65%) 231,893 119,473 181 (0.08%) 134 (0.1%)
L1 830,062 486,901 (58%) 282,146 204,755 219 (0.08%) 250 (0.1%)
L2 375,116 240,350 (64%) 154,309 86,041 103 (0.07%) 72 (0.08%)
CR1 50,156 33,365 (66%) 22,087 11,278 12 (0.04%) 6 (0.05%)
LTR 654,897 292,456 (44%) 136,461 155,995 155 (0.1%) 150 (0.09%)
DNA 389,688 226489 (58%) 145,968 80,521 93 (0.06%) 142 (0.17%)
Total 3,932,058 2,349,387 (60%) 1,452,916 896,471 1824 (0.12%) 1653 (0.18%)
Insertions of transposed elements (TEs) within the human genome. The different classes of the examined TEs are shown in the left column. 'Total' 
(second column) indicates the overall amount of each TE within the human and mouse genomes. 'Intronic' (third column) indicates the number of 
TEs within intronic regions, and the percentage of TEs within introns relative to the total amount of TEs is shown in parentheses brackets. The 
fourth and fifth columns show the number of TEs within introns of the University of California, Santa Cruz (UCSC) knownGene list (version hg17) 
and those inserted within genes not listed within UCSC knownGene list. The sixth and seventh columns show the number of exonized TEs within 
the UCSC knownGene list and those exonized within genes not listed within UCSC knownGene list. In parentheses are indicated the percentage of 
exonized TEs is indicated. The lower row shows the total number of all TEs. aGene annotation is based on the annotations of the known gene list in 
the UCSC genome browser (version hg17). LTR, long terminal repeat; MIR, mammalian interspersed repeat; RE, retroelement.R127.4 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. http://genomebiology.com/2007/8/6/R127
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intronic TEs (also see Materials and methods, below). In
humans, 0.12% of the TEs exonized within protein coding
genes (1,824 TE exonizations out of 1,452,916 TEs in introns)
and 0.18% of the TEs exonized within non-protein-coding
genes (1,653 out of 896,471). In contrast, we found a 0.06%
rate of exonization within protein coding genes (506 out of
888,768) and 0.08% (722 out of 942,164) in non-protein-
coding genes in the mouse transcriptome. The higher level of
exonization in human compared with that in mouse is signif-
icant even after normalization of the relative EST/cDNA cov-
erage (7.9 million transcripts in human versus 4.7 million
transcripts in mouse - a ratio of 1.7). That is, even if we multi-
ply the exonization of mouse by 1.7, there is still significantly
higher exonization in the human genome (χ2 Fisher's exact
test; P < 10-29 [degrees of freedom = 1] for protein-coding
genes and P < 10-19 [degrees of freedom = 1] for non-protein-
coding genes, for a multiplication by 1.7 of the exonization
level within the mouse genome).
When the dataset was further reduced to exons in which there
were at least two ESTs/cDNAs, confirming their exonization,
we also observed a higher exonization level within human
genome: 0.05% exonization in human both in coding and
non-protein-coding genes, versus 0.03% and 0.02% in mouse
coding and non-protein-coding genes, respectively (χ2; P <
10-16 [degrees of freedom = 1] for protein-coding genes and P
< 10-22 [degrees of freedom = 1] for non-protein-coding genes;
see Additional data file 1). The importance of long non-pro-
tein-coding RNA was recently demonstrated in human tran-
scripts [29]. We therefore present an example of an
exonization within a non-protein-coding gene (Additional
data file 5). The fact that more than 50% of our data are sup-
ported by only one item of EST/cDNA evidence raises ques-
tions regarding the fidelity of the spliceosome (see
Discussion, below).
Several TE families are located in the human and mouse
genome, including MIR, L1, L2, CR1 (L3), LTR, and DNA
repeats; thus, we can expect there to be a substantial amount
of orthologous TE exons (exonization of the same TE in the
human-mouse ortholog gene) in these families. However,
only six TE exons were found to be orthologous, of which four
are exonizations of MIR elements and two are exonizations of
DNA repeats. It is doubtful that these are two independent
insertion events because MIR and DNA repeats were active in
common ancestors of all mammals, and because independent
insertion into precisely the same locus is very rare. We there-
fore suggest that these MIR and DNA repeats were inserted
into a common mammalian ancestor. These exons could
either result from independent exaptation in the separated
lineages or occur as a result of one exaptation event in the
human-mouse common ancestor.
Do all TEs have the same exonization potential? That is, do all
intronic TEs exhibit the same probability for acquiring muta-
tions that subsequently lead the splicing machinery to select
them as internal exons? Our analysis reveals that the majority
of TE families exhibit similar exonization capabilities, at
around 0.07% in both human and mouse (meaning 0.07% of
the intronic TEs exonized). Statistical analysis indicated that
there was no difference in the level of exonization of MIR, L1,
L2, and CR1 and DNA within the human genome (χ2 = 5.25; P
Table 2
TE effect on the mouse transcriptome
RE Total Intronic TE in introns of UCSC 
annotated genesa
TE in introns of non-
annotated genesa
TE exonization in UCSC 
annotated genesa
TE exonization in non-
annotated genesa
B1 506,528 331,015 (65%) 189,268 141,747 134 (0.07%) 96 (0.07%)
MIR 116,355 66,597 (63%) 41,853 24,744 27 (0.06%) 14 (0.06%)
B2 338,642 215,264 (63%) 118,646 96,618 81 (0.07%) 80 (0.08%)
B4 345,646 216,550 (66%) 119,827 96,723 62 (0.05%) 72 (0.07%)
ID 45,955 30,285 (57%) 18,022 12,263 8 (0.04%) 3 (0.02%)
L1 820,434 457,705 (56%) 181,292 276,413 102 (0.07%) 189 (0.07%)
L2 56,518 34,923 (62%) 18,963 15,960 9 (0.05%) 5 (0.03%)
CR1 11,812 7,167 (61%) 3,779 3,388 0 (0%) 1 (0.03%)
LTR 756,324 396,226 (52%) 156,690 239,536 72 (0.05%) 243 (0.1%)
DNA 124,202 75,200 (60%) 40,428 34,772 11 (0.02%) 19 (0.05%)
Total 3,122,416 1,830,932 (58%) 888,768 942,164 506 (0.06%) 722 (0.08%)
Insertions of transposed elements (TEs) within the mouse genome. The different classes of the examined TEs are shown in the left column. 'Total' 
(second column) indicates the overall amount of each TE within the human and mouse genomes. 'Intronic' (third column) indicates the number of 
TEs within intronic regions, and the percentage of TEs within introns relative to the total amount of TEs is shown in parentheses. The fourth and fifth 
columns show the number of TEs within introns of University of California, Santa Cruz (UCSC) knownGene list (version mm6) and those inserted 
within genes not listed within UCSC knownGene list. The sixth and seventh columns show the numbers of exonized TEs within the UCSC 
knownGene list and those exonized within genes not listed within UCSC knownGene list. In brackets are indicated the percentage of exonized TEs. 
The lower row shows the total number of all TEs. aGene annotation is based on the annotations of the known gene list in the UCSC genome 
browser (version hg17). LTR, long terminal repeat; MIR, mammalian interspersed repeat; RE, retroelement.http://genomebiology.com/2007/8/6/R127 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. R127.5
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= 0.26 [degrees of freedom = 4]), although LTR exonization
in human was higher, compared with that of other SINEs,
LINEs, and DNA repeats, but still substantially lower than
Alu. Also, there were also no differences in exonization level
between B1, B2, B4, ID, MIR, L1, L2, and CR1 within the
mouse genome (χ2 = 10; P = 0.18 [degrees of freedom = 7]),
and LTR and DNA exhibited a slightly lower level of exoniza-
tion in mouse. An exceptional case was the Alu exonization
level, which was almost three times higher than that of all
other TE families, with more than 0.2% of its intronic copies
being exonized (all χ2 test values are listed in Additional data
file 2). In addition, no differences were found in exonization
level between the human and mouse MIR element, L2, and
CR1. Interestingly, L1 exonization levels were higher in
human than in mouse, and there was also a higher exoniza-
tion level of LTR and DNA repeats in human compared with
mouse. However, the L1 populations were different between
human and mouse genomes (Additional data file 7), and the
LTR and DNA populations were very heterogeneous. The LTR
of the mouse was very abundant with the younger retroviral
class II (ERVK), in which almost no exonization was detected.
In summary, these findings indicate that the Alu sequence is
a better substrate for the exonization process, as compared
with all other TE families. The higher level of exonization for
Alu could be due to many 'unproductive' Alu exonizations,
which were 'weeded out' in older exonizations. However, our
comparison of TE families that were inserted into the genome
at around the same time as Alu (L1 in human and B1, B2, and
B4 in mouse) and which exhibited a much lower level of
exonization than that of Alu probably indicates that Alu is a
much better sequence for the exonization process than the
others.
Do transposed element exonizations have tissue 
specificity and cancer characteristics?
To examine TE exons that may be spliced differently among
tissues, we used a bioinformatics analysis approach devel-
oped previously to identify tissue-specific exons [30]. We
found 74 exons in human and 18 exons in mouse that puta-
tively undergo tissue-specific splicing. In human, 41 exons
belong to Alu, seven are MIR exons, seven are L1 exons, two
are L2 exons, one is a CR1 exon, ten are LTR exons, and seven
are DNA exons. In mouse, five are B1 exons, four are MIR
exons, one is a B4 exon, one is an L1 exon, one is an L2 exon,
and six LTR exons. (All of these exons are listed in Additional
data file 13; the SINE, LINE, LTR, and DNA exons with tissue
specificity score above 95 are listed in Additional data file 10
(parts B and C).
A bioinformatics approach to identifying exons that changed
their splicing regulation in cancer is described by Xu and Lee
[31]. We used this approach to analyze our data. We identified
36 such exons in human and 10 in mouse (listed in Additional
data file 13). We further filtered our data to search for exons
that were intronic within normal tissues and recognized as
exons only within cancerous tissues and hence can serve as a
potential marker for cancer diagnostics. Six such exons were
found in six different genes (ACAD9, YY1AP, KUB3, AMPK,
NEL-like 1 and active BCR-related gene) and all of them were
primate-specific Alu exons (Additional data file 10 [part A]).
All exons were found within the coding sequence (CDS): in
the  YY1AP,  NEL-like1  and  active BCR-related gene they
introduce a stop codon, whereas in ACAD9 and KUB3 they
cause frame shifts. It was only the Alu exon in AMPK that did
not have a deleterious effect on the protein (it did not intro-
duce a stop codon or cause a frame shift) and was not found
to introduce a known protein domain. Except for the exoniza-
tion within the NEL-like-1 gene in which the isoform skipping
the Alu exon (meaning the ancestral isoform) could not be
detected within cancerous tissues, in all other genes the
ancestral isoform was present within the cancerous tissue as
well, probably only leading to reduction in the ancestral iso-
form concentrations. In one of these genes, namely ACAD9,
we experimentally observed exonization in two ovarian can-
cer cell lines, but not in mRNA extracted from seven nonovar-
ian cell lines (Additional data file 12).
Can we detect exonized transposed elements that are 
not alternatively spliced?
The 1,824 human and 506 mouse TE exons can affect the
transcriptomes in many different ways. In our data, 94% of
the exonizations in human and 88% of the exonizations in
mouse generated an internal cassette exon (Figure 1a [ii]; as
was also reported elsewhere [3-5]). In the rest of the cases, the
exonization formed alternative 5' splice sites (5'ss), alterna-
tive 3' splice sites (3'ss), or constitutively spliced exons. The
numbers of the different splice forms of the TE exons in
human and mouse are shown in Figure 1a. In the majority of
cases, the alternative 5'ss or 3'ss is generated when an exon is
alternatively elongated as a result of an alternative 5'ss or 3'ss
selection within the TE (Figure 1a [iii] and 1a [iv], respec-
tively). Also, in 3.1% and 5.7% of the human and mouse TE
exonizations, respectively, the exons are detected in silico as
constitutively spliced. In most of these cases (71%) the consti-
tutively spliced exons were found in the untranslated region
(UTR), and in 12.2% of the cases the constitutively spliced
exon entered within the CDS and is 'divisible by 3' (preserve
the reading frame, also termed symmetrical). In the rest of
the cases, when the exonization is within the CDS and is not
'divisible by 3', the gene encodes a hypothetical protein.
Exon 2 of the DMWD gene originated from exonization of a
MIR element. This exon is highly conserved within the mam-
malian class. Figure 2a,b show the alignments of the exon
among human, chimpanzee, rhesus, mouse, rat, dog, and cow
ortholog. The divergence of that exon, relative to the consen-
sus MIR sequence, is high (about 25%). However, following
exonization the exon is highly conserved among the species.
This implies that once the exon has undergone exaptation and
acquired a function, a purifying selection prevents accumula-
tion of mutations. The high level of protein conservationR127.6 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. http://genomebiology.com/2007/8/6/R127
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(Figure 2b) suggests that exaptation occurred before the
human, mouse, rat, dog, and cow split.
From the four MIR orthologous exons, two were selected for
experimental validation. One was selected to show the con-
served alternative splicing pattern between human and
mouse, and the other to show the conserved constitutively
spliced pattern between human and mouse. The Alu was cho-
sen randomly from all constitutively spliced Alu exons found
in our analysis. Figure 2c shows the validation of the splicing
pattern of three exons. The first exon originating from MIR is
conserved between human and mouse, and is alternatively
spliced in both species (exon 2 of DMWD gene; Figure 2c,
lanes 1 and 2); the second also originates from MIR, and is
conserved between human and mouse, but it is constitutively
spliced (exon 5 of MYT1L gene; Figure 2c, lanes 3 and 4); and
the third one is an Alu exon, which is constitutively spliced
(exon 3 of FAM55C gene; Figure 3c, lane 5). This reverse tran-
scription polymerase chain reaction (RT-PCR) analysis con-
firms that, under the above conditions and within the
examined tissues, we can detect only one isoform that con-
tains the exonization. This observation cannot exclude the
possibility that this exon is alternatively spliced within other
tissues or under different conditions.
Transposed element insertion into last and first exons 
of the untranslated region
Furthermore, our analysis shows that the influence of TEs on
the transcriptome is not limited to the creation of new inter-
nal exons from intronic TEs (exonization); TEs can also mod-
ify the mRNA, by being inserted within the first or last exon of
a gene. The insertion causes an elongation of the first/last
exons that are usually part of the UTR or an activation of an
alternative intron (termed intronization; Figure 1b [ii to iv],
How TEs affect the human and mouse transcriptome Figure 1
How TEs affect the human and mouse transcriptome. (a) Summary of the effect of (i) exonization of TEs on the transcriptome; of the effect of exonization 
that (ii) creates an alternatively skipped exon, (iii) transforms an existing exon to an alternative 5'ss exon, or (vi) transforms an existing exon to an 
alternative 3'ss exon; or of the effect of exonization that (v) creates a constitutively spliced exon. The table on the right shows the corresponding numbers 
of transposed elements (TEs). (b) Summary of the effect of TE insertions in the first or last exon. Panel i shows the insertion of TEs (gray box) into an 
exon (white box). The insertion of the TEs can cause an enlargement of the first or last exon (panels ii and iii), or, in some cases, activates intronization 
(generating an alternatively spliced intron that splits the last exon into two smaller exons; panel iv). The numbers of those events according to TE family 
are shown on the right-hand side.
5’ss 3’ss
(i)
(ii)
(iii)
5’ss
3’ss
(iv)
5’ss 3’ss
(v)
(i)
(ii)
EXON
RE
(a)
(b)
Human Mouse
Alu MIR L1 L2
1020(96%) 158(87%) 210(96%) 93(90%)
RE
Alt. 5’ss
Alt. 3’ss
Const.
Alt. Skip
8(1%) 4(2%) 0(0%) 5(5%)
8(1%) 7(4%) 0(0%) 1(1%)
24(2%) 12(7%) 9(4%) 4(4%)
B4 MIR L1 B2 B1
125(94%) 74(91%) 54(87%) 22(81%) 98(96%)
3(2%) 1(1%) 1(2%) 0(0%) 1(1%)
3(2%) 0(0%) 1(2%) 2(8%) 0(0%)
3(2%) 6(8%) 6(9%) 3(11%) 3(3%)
Human Mouse
Alu MIR L1 L2
5030 2073 2024 132
RE
Insertion 
5UTR
B4 MIR L1 B2 B1
435 245 256 96 275
Total
(iii)
(iv)
Intron 
retention 
3UTR
Insertion 
3UTR
CR1
1176
1115 524 561 23 314
3911 1549 1463 109 862
40 00 0
L2 CR1
41 5
2480 1050 1120 406 792 160 28
000 00 0 0
2915 1295 1376 502 1067 201 33
RE
5’ UTR
3’ UTR
3’ UTR
LTR DNA
8(6%)
145(93%)
1(0.5%)
1(0.5%)
1(1%)
91(97%)
1(1%)
1(1%)
LTR DNA
7(10%)
65(90%)
0(0%)
0(0%)
10(91%)
0(0%)
0(0%)
1(9%)
LTR DNA LTR DNA
786
1456
0
363
1191
0
2242 1554
492 87
1373 438
00
1865 525http://genomebiology.com/2007/8/6/R127 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. R127.7
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RT-PCR analysis of selected Alu and MIR exons Figure 2
RT-PCR analysis of selected Alu and MIR exons. (a) Multiple alignment of mammalian interspersed repeat (MIR) exon in DMWD gene among mammals. 
Exon sequences are marked in blue, flanking intronic sequences are marked in black, and the canonical AG and GT dinucleotides at the 3'ss and 5'ss are 
marked in red. Nucleotide conservation is marked at the lower edge, with asterisks indicate full conservation and colons indicating partial conservation 
relative to the MIR consensus sequence (lower row). The divergence in percentage from the consensus MIR sequence is indicated under (MIR div); exon 
conservation in percentage compared with the human exon is indicated under (exon conserve); EST/cDNA accession confirming the exon insertion is 
indicated under (cDNA/EST holding evidence), and skipping is indicated under (cDNA/EST skipping evidence). Nonconserved nucleotides are marked in 
yellow. (b) This panel is similar to panel a, except that the conservation is shown for the protein coding sequence. (c) Total RNA was collected from SH-
SY5Y human cell line and mouse brain tissue. Reverse transcription polymerase chain reaction (RT-PCR) analysis amplified the endogenous mRNA 
molecules using primers specific to the flanking exons. The PCR products were separated on an agarose gel, extracted and sequenced. A schema of the 
mRNA products is shown on the left and right. Columns 1 to 4 show the splicing pattern of orthologous human (H) and mouse (M) exons originating from 
the MIR element. Columns 1 and 2 show alternative splicing of an ortholog MIR element in both human and mouse, respectively (exon 4 in DMWD gene), 
and columns 3 and 4 show a constitutive pattern in both species (exon 5 in the MYT1L gene). Column 5 shows constitutive splicing of an Alu element in 
the human exon 3 of FAM55C gene. All PCR products were confirmed by sequencing. We cannot fully reject the option that an exon that is constitutively 
spliced under the above conditions is alternatively spliced in other cells or conditions. However, the constitutive selection is also supported by EST/cDNA 
coverage.
Alignment of DMWD 
3'ss
Human    acccctctgtctccgtagTTCACAGACGAGGAGACCGA-GGCCCAGACAGGGGAAGGAAGTTGGCCCAGGTC
Chimp    acccctctgtctccgtagTTCACAGACGAGGAGACCGA-GGCCCAGACAGGGGAAGGAAGTTGGCCCAGGTC
Rhesus   acccctctgtctccctagTTCACAGACGAGGAGACCGA-GGCCCAGACAGGGGAAGGAAGTTGGCCCAGGTC
Mouse    acccctctgtctccctagTTCACAGACGAGGAGACCGA-GGCCCAGGCAGGGCAAGCAAGTTGGCCCAGGTC
Rat      tgccctctatctccntagTTCACAGACGAGGAGACCGA-GACCCAGGCAGGGGAAGCAAGTTGGCCCAGGTC
Dog  acccctctatctccctagTTCACAGACGAGGAGGCCGA-GGCCCAGACAGGGGAAGGAAGTTGGCCCAGGTC
Cow      acccctctatctccctagTTCACAGATGAGGAGACCGA-GGCCCAGACAGGGGAAGGAAGTTGGCCCAGGTC
MIR      gtgcctcagtttcctcatCTGTAAAATGGGGATAATAATAGTACCTACCTCATAGGGTTGTTGTGAGGATTA
            **** :* ***  *  *   * * * *** :   *  :  *  :*     * *:  ****       * 
                                                                 cDNA/EST  cDNA/EST 
MIR Exon    holding   skipping 
div conserve evidence evidence
Human ACCCAGCAAGTCAGTGGTAGAGg—-taggactgtccct  25.9%   100%   NM_004943  BC019266 
5'ss
Chimp ACCCAGCAAGTCAGTGGTAGAGg—-taggactgtccct  25.9%   100%       -        - 
Rhesus ACCCAGCAAGTCAGTGGTAGAGg--taggactgtccct  23.2%   100%       -        - 
Mouse ACCCAGCAAGTCAGTTGTAGAGg—-taggacaacccct  29.4%    94%    AK086899  BC089027 
Rat ACCCAGCAAGTCAGTGGTAGAGg—-taggacaaccccc  29.7%    96%    AW141441  BU758446
Dog ACCCAGCAAGTCAGTGGTAGAGg—-taggatcgtccct  26.9%    98%    DN369153  DN748025
Cow ACCCAGCAAGTCAGTGGTAGAGg—-taggactgtccct  22.4%    98%    DV927214  DT830173
MIR      AATGAGTTAATACATGTAAAGCgcttagaacagtgcct
         *   **  * *   *:  *   *  *** *: :: **: 
Human    FTDEETEAQTGEGSWPRSPSKSVVE 
Chimp    FTDEETEAQTGEGSWPRSPSKSVVE 
Rhesus   FTDEETEAQTGEGSWPRSPSKSVVE 
Mouse    FTDEETEAQAGQASWPRSPSKSVVE 
Rat      FTDEETETQAGEASWPRSPSKSVVE 
Dog      FTDEEAEAQTGEGSWPRSPSKSVVE 
Cow      FTDEETEAQTGEGSWPRSPSKSVVE 
(c)
(a)
(b)
M
H
_
M
Y
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1
M
_
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Y
T
1
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D
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W
D
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D
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C
12 34 5R127.8 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. http://genomebiology.com/2007/8/6/R127
Genome Biology 2007, 8:R127
Figure 3 (see legend on next page)
(iii)
5’ss 3’ss
(a)
(i)
(ii)
-AluJo +AluSq
Intronization
(b)
HM
CWF19L1 intron alignment  
 
 
Human  AATGTTCCTGATAAGTCTGACTGGAGGCAGTGTCAGATCAGCAAGGAAGACGAGGAGACCCTGGCT 
Mouse AACATTCCTGAGAAGGCTGACTGGAGGCAGTGTCAAACCAGCAAGGACGAGGAGGAGGCCCTGGCC 
Rat   AACATTCCTGAGAAGGCTGACTGGAGGCAGTGTCAAACCAGTAAGGATGAGGAGGAGGCCCTGGCT 
Dog   AATATTCCTGACAAGTCTGACTGGAGGCAATGTCAGCTCAGCAAGGAAGAGGAAGAGATGCTGGCT 
 
Human CGCCGCTTCCGGAAAGACTTTGAGCCCTATGACTTTACTCTGGATGACTAAaacaaagggaagaac 
Mouse CGCCGCTTCCGGAAAGACTTTGAACCCTTTGACTTCACTCTGGATGACTAGc-caaaggggagggc 
Rat   CGCCGCTTCAGGAAAGACTTTGAACCCTTTGACTTCACTCTGGATGACTAGc-caaagggaagggc 
Dog   CGCCGCTTCCGGAAAGACTTTGAGCCCTTTGACTTCACTCTGGATGACTAAg-taaagggaaaggc 
 
Human tttttatgaactccacaggaagtagtaaagcttttttttttttttaattaaaagaattttttttga 
Mouse acctcaggtcaccgactggaac-agcagatt----------------------------------- 
Rat   ------------------------------------------------------------------ 
Dog   actttatgaacttgacaggaagta------------------------------------------ 
 
 
Human gacaaagtctcgctctgtcacccaagcaggattgcagtggcataactgtggctcactgtagcctca 
Mouse ------------------------------------------------------------------ 
Rat   ------------------------------------------------------------------ 
Dog   ------------------------------------------------------------------ 
 
 
Human acctcctgggctctagagttcctcccacctcagcctcatgagtagctgggaccacaggcgcatgct 
Mouse ------------------------------------------------------------------ 
Rat   ------------------------------------------------------------------ 
Dog   ------------------------------------------------------------------ 
 
Human accatgcctggcaaacttttttgattttttatagagacaggagggtctccctgtgttgcccaggct 
Mouse ------------------------------------------------------------------ 
Rat   ------------------------------------------------------------------ 
Dog   ------------------------------------------------------------------ 
 
Human ggtctgtaatgcctaggctcaagggatcctctgccttggcttcttaacctgctgggattacaagca 
Mouse ------------------------------------------------------------------ 
Rat   ------------------------------------------------------------------  
Dog   ------------------------------------------------------------------ 
 
Human tgagac-accattcctggcctagaagcctatttttaaagaaactacaatctcccatggggactgtt 
Mouse -----------------g-ttccaa-cctgctcttaaaatggagttaccgtctcgtgggagctgcc 
Rat   ----------------ag------cctgttctgaaagtgaaactacagtctctcgtaggggctgcc 
Dog   -----------------ttagtagcttgttttttttaagaaactacagtctcccatggggactgtt 
 
Human tccctgcctcttttgtgcagtcccatggaacttgcctacagcaagaggcct--aagattgaatctt 
Mouse tccctgcctctt—-caatatattcccatggacctgcctgctgcaggaggcctct-gattga-cttt 
Rat   cccttcctctttttcagtatattcccatggacccgcctgcagtaggaggcctct-ga-----tttt 
Dog      actctgcctcttttttgtgcattcctatggaacctgcctgcagcaagaggcttgaaa--ttatttt 
 
Human tttggggaaaagtcattctaggatgaaaatcctatgttaaggccgggcgcagtggctcacgcctgt 
Mouse tt—aaaaagaagtcattctgagatgcaatga-taagttaa-------------------------- 
Rat   t---aaaagaagtcattttgagattcaat-a-t—-gttaa-------------------------- 
Dog   ttggaaaataattgt---aggatgaaaatcct---gttaa-------------------------- 
 
Human aatcccagtactttgggaagccgaggcaggtggatcacctgaggtgaggagtttgagaccagcctg 
Mouse ------------------------------------------------------------------ 
Rat   ------------------------------------------------------------------ 
Dog   ------------------------------------------------------------------ 
 
Human gccaacatggtgaaaccccgtctttactaaagctacaaaaattagctgggcgtggtgccaggcact 
5'ss   
(c)
Mouse ------------------------------------------------------------------
Rat   ------------------------------------------------------------------
Dog   ------------------------------------------------------------------
Human tgtaatcccagctactcaggaggctgaggcaggagaattgcttgagcctgggaggtggaggttgca
Mouse ------------------------------------------------------------------
Rat   ------------------------------------------------------------------
Dog   ------------------------------------------------------------------
Human gtgagccaagatcgctccattgcactccagcctgggtgacagtgaaactccatctcaaaaataaaa
Mouse ------------------------------------------------------------------
Rat   ------------------------------------------------------------------
Dog   ------------------------------------------------------------------
Human gaataaaagtatgtctgtcatccagctcctatgtctgttatccagctccaagtacagcttgtgtat
Mouse ------------------------------acatctgctatgtatttctaagaacagct-ctgttt
Rat   ------------------------------acatctgctacatatttctaaga-cagct-ctgttt
Dog   ------------------------------atgtctgtcatccagctccaagtacagcttatgtta
Human atcaacattttcaaaaacctttaaac
Mouse ctcctcatcctcacaaacttttaaac
Rat   ctccacatcctcacaaacttttaaac
Dog   atcaaaattttcagaaaca-ttaaac
3'ss   
-AluJo
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respectively). The analysis of the number of TE insertions
within the first or last exon in human and mouse was done on
UCSC annotated genes, in which a consensus mRNA
sequence exists. We searched for TE insertions within the
first and last exon of 19,480 human and 16,776 mouse genes
that are listed as known genes in the UCSC genome browser.
In human annotated genes, the average length of the first and
last exon is 464.6 base pairs) and 1,300 bp, respectively. In
contrast, in mouse genes the first exon has an average length
of 392.7 bp and the last exon an average length of 1,189 bp.
Our analysis revealed that 3,686 TEs were inserted within the
first and 10,541 TEs within the last exon of the human tran-
scriptome. In the mouse transcriptome, 1,932 and 7,847 TEs
were inserted into the first and last exons, respectively (Fig-
ure 1b). On average, the human transcriptome is significantly
enriched with TEs: 3.5% and 7.6% of the first and last exons
in human coding genes contain TE insertions, as compared
with 0.4% and 1.7% of first and last exons in mouse coding
genes that contain TE insertions (Mann-Whitney; first exon P
= 0 and last exon P = 0). One-third of all TE insertions within
the human first and last exons belong to Alu  (35.3%),
although Alu elements comprise only 27.9% of TEs within the
human genome (χ2; P < 10-9 [degrees of freedom = 1]). When
normalizing for the differences in length of the first and last
exons, there is no bias for TE insertion within either the first
or the last exon of the gene.
Alu element insertion generates new introns
We found four cases in which the insertion of the Alu element
into the last exon of the gene was involved in the activation of
an alternative intron (called intron retention) within the 3'-
UTR of the gene (primate-specific intron gain events). Here,
new splice sites were introduced within the last exon of the
gene. These events occurred within the SS18L1,  PDZD7,
C14orf111, and CWF19L1 genes (illustrated in Figure 1b [iv]).
In the SS18L1 gene, in which the Alu was inserted in the sense
orientation, three mutations within the Alu sequence acti-
vated a 5'ss, whereas the 3'ss and the polypyrimidine tract
(PPT) was contributed from the conserved area of the exon.
In the CWF19L1 gene, the last exon is conserved within the
mammalian class. Two Alus were inserted into that exon, one
in the sense orientation and the other in the antisense orien-
tation, and the 5'ss and 3'ss were contributed by antisense
AluJo and by the sense AluSx, respectively (shown in Figure
3a,c). Examination of the splic i n g  p a t t e r n  o f  t h i s  e x o n  i n
human and mouse by RT-PCR revealed that the exon is con-
stitutively spliced in mouse (Figure 3b, lane 3). However, in
human, the same analysis on kidney normal tissue detected
two RNA products: intron retention isoform (upper PCR
products; Figure 3b, lanes 1 and 2) and spliced product using
3' and 5' spliced sites within the Alus (Figure 3b, lane 1, lower
RCR product). See Figure 3a for a graphical illustration of
these splice sites and Figure 3c for their location along the
exonic sequence. The spliced intron is flanked by a canonical
5'ss of the 'GC' type and a noncanonical 3'ss of 'tg' instead of
'ag' (see Figure 3c). The identity of these splice sites was con-
firmed by sequencing and was supported by 12 cDNA/EST as
well, indicating that the same noncanonical splice site is used
in all cases (for the list of these cDNA/ESTs, see Additional
data file 8). We currently cannot explain how the splicing
machinery selects a noncanonical splice site, although it was
shown previously that a 'tg' spliced site can serve as a func-
tional 3'ss [32,33]. Additionally, it may also be related to RNA
editing, because of formation of dsRNA between the sense
and antisense Alu (see, for example, the report by Lev-Maor
and coworkers [16]). This hypothesis is supported by detec-
tion of potential deviation between the genomic sequence and
some of the cDNA in the flanking exonic sequences. However,
further analysis is needed to understand this phenomenon
fully.
With regard to the last two genes exhibiting intronization, the
C14orf111 and PDZD genes, the last exon is not conserved
within mammals. In the C14orf111 gene the last exon com-
prises L1, three Alu  elements, and an LTR insertion. The
intron retention is spliced by a 3'ss and a 5'ss that are found
within the Alu sequences (Genebank accession BC08600 and
BX248271 confirm the splicing of the intron, and BX647810
confirm the unspliced intron). In the PDZD gene there were
two Alu insertions. Both the 3'ss and the 5'ss are found within
the Alu sequence (Genebank accession BC029054 confirm
the splicing of the intron and AK026862 confirm the
unspliced intron). All of these cases are within the last exon of
the gene, within the 3'-UTR. The intronizations generate an
alternative intron, that is, both the Alu insertion and spliced
forms are present in the mRNA.
Short interspersed nuclear elements tend to exonize in 
the antisense orientation
Our dataset shows that Alu and MIR have a statistically sig-
nificant bias toward exonization in their antisense orienta-
tion, relative to the direction of the mRNA in the human
transcriptome. Additionally, B1, MIR, B2, and B4 are biased
Alu insertions into an exon activate intronization in the CWF19L1 gene Figure 3 (see previous page)
Alu insertions into an exon activate intronization in the CWF19L1 gene. (a) Intronization. (i) Illustration of the last exon of the CWF19L1 gene in mouse. 
(ii) During primate evolution, two Alu elements were inserted into the exon. (iii) Because of these insertions, an intronization process activates two splice 
sites within the exon, a 3' and a 5' splice site. The isoform in which the intron is spliced out is supported by 12 mRNA/expressed sequence tags (ESTs), and 
the isoform in which the intron is retained is supported by four mRNA/ESTs. (b) Testing the splicing pathway of this exon between human and mouse. 
Polymerase chain reaction (PCR) analysis on normal cDNAs from human kidney (marked H) and from mouse brain tissue (marked M). PCR products were 
amplified using species-specific primers, and splicing products were separated in 1.5% agarose gel and sequenced. (c) Alignment of the sequence of the last 
exon of the CWF19L1 gene among human, mouse, rat, and dog is shown. The two Alu elements are marked in gray. The selected 5'ss and 3'ss are marked.R127.10 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. http://genomebiology.com/2007/8/6/R127
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toward the antisense exonization in the mouse transcriptome
(see Tables 3 and 4, columns 2 and 3). We correlate this phe-
nomenon with the fact that, in most cases, SINE elements
contain a polyA tail at the end of their sequence. In the anti-
sense direction, this polyA becomes a polypyrimidine tract
that facilitates exonization [4,5]. LINEs and DNA repeats in
both human and mouse do not exhibit a preferential exoniza-
tion orientation (the greater number of L1 exonizations in the
antisense is caused by its biased insertion in the antisense
direction within introns, and not because of a preferential
exonization in the antisense orientation). LTRs exhibit a
biased exonization in their sense orientation in both human
and mouse (for χ2 test P value, see Additional data file 3).
Alu, L1, and long terminal repeat have the highest 
capability to contribute a whole exon
An exonization can occur if the TE contributes only a 5'ss or
3'ss to the exon or by using both intrinsic 5'ss and 3'ss within
the TE (entire exon). We divided our TE exon dataset into
three groups: those that contributed a whole exon and those
that contributed only a 5'ss or only a 3'ss (Tables 3 and 4, col-
umns 4 to 6, respectively). In 66% of exonized Alu and LTR
and 68% of exonized L1 elements in the human transcrip-
tome, the whole exon is contributed by the TE. In the mouse
transcriptome, 75% of exonized L1 and 67% of exonized LTR
are entire exons. In contrast, all other TE exonizations con-
tribute a complete exon in approximately 40% of the cases,
rates that are significantly lower than those for Alu, L1, and
LTR (χ2; P < 10-3 [degrees of freedom = 6] for human and P =
0.05 [degrees of freedom = 5] for mouse). The reason for the
high level of Alu exonization is the low number of mutations
needed to activate potent splice sites [4,5], as well as the pres-
ence of enhancers and silencers that were previously reported
to reside within the Alu consensus sequence [34]. This obser-
vation suggests that Alu, L1, and LTR TEs have greater poten-
tial to be recognized by the spliceosome machinery, and
probably many copies of these TEs serve as 'pseudo-exons'
(intronic Alu sequences containing putative 5'ss and polypy-
rimidine tract-3'ss that are one mutation away from exoniza-
tion) within introns of protein coding genes [4,5].
Table 3
Architecture of the newly recruited exons in the human genome
RE Sense Antisense Whole 5'ss 3'ss
Alu 139 (13%) 921 (87%) 701(66%) 240 (23%) 119 (11%)
MIR 60 (33%) 121 (67%) 68 (38%) 62 (34%) 51 (28%)
L1 62 (28%) 157 (72%) 149 (68%) 34 (16%) 36 (16%)
L2 41 (40%) 62 (60%) 42 (41%) 31 (30%) 28 (29%)
CR1 4 (33%) 8 (67%) 6 (50%) 3 (25%) 3 (25%)
LTR 68 (44%) 87 (56%) 103 (66%) 19 (10%) 33 (24%)
DNA 47 (50%) 46 (50%) 46 (50%) 22 (23%) 25 (27%)
The first column indicates the different transposed elements (TEs) that were examined. In columns 2 and 3, the numbers of exonizations in the sense 
and antisense orientations are shown. The percentages of the total number of exonizations are given in parentheses. In columns 4, 5, and 6, the 
numbers of exons are given in which the TE contributes the whole exon, the 5', and the 3' part of an exon, respectively. In parentheses are given the 
percentage of the total number of exonizations. LTR, long terminal repeat; MIR, mammalian interspersed repeat; RE, retroelement.
Table 4
Architecture of the newly recruited exons in the mouse genome
RE Sense Antisense Whole 5'ss 3'ss
B1 34 (24%) 108 (76%) 58 (41%) 55 (39%) 29 (20%)
MIR 5 (18%) 23 (82%) 12 (43%) 8 (28.5%) 8 (28.5%)
B2 23 (28%) 60 (78%) 35 (42%) 31 (36%) 19 (23%)
B4 20 (31%) 45 (69%) 26 (40%) 17 (26%) 23 (34%)
L1 47 (46%) 56 (54%) 77 (75%) 15 (14.5%) 12 (10.5%)
L2 1 (9%) 10 (91%) 3 (28%) 4 (36%) 4 (36%)
LTR 35 (49%) 37 (51%) 48 (67%) 10 (14%) 14 (19%)
DNA 6 (54%) 5 (46%) 4 (36%) 4 (36%) 3 (28%)
The first column indicates the different transposed elements (TEs) that were examined. In columns 2 and 3, the numbers of exonizations in the sense 
and antisense orientations are shown. The percentages of the total number of exonizations are given in parentheses. In columns 4, 5, and 6 are 
shown the numbers of exons are given in which the TE contributes the whole exon, the 5', or the 3' part of an exon, respectively. In parentheses, the 
percentages out of the total number of exonizations are given. LTR, long terminal repeat; MIR, mammalian interspersed repeat; RE, retroelement.http://genomebiology.com/2007/8/6/R127 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. R127.11
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Do transposed element exonizations enter with the 
same probability in all parts of the mRNA?
A new exon resulting from TE exonization can reside either
within the CDS or the UTR. When inserted within the UTR,
the exon can introduce an alternative start-of-coding
sequence or it can enlarge the UTR. The different number of
exonizations within the mRNA for different TEs is summa-
rized in Tables 5 and 6 (columns 2 to 4) for human and mouse
data, respectively. More than 32% of all exonized TEs in both
human and mouse are inserted within the UTR regions. To
check whether exonization has a bias toward insertion in the
UTR or the CDS, we estimated the fraction of the UTR and
CDS within human and mouse genes, based on the annota-
tions of 19,480 and 16,776 human and mouse genes, respec-
tively (see Materials and methods, below). In human, the
average gene length is 59,186 nucleotides, in which 79% and
21% are CDS and UTR sequences. In mouse, the average gene
length is 49,101, in which 73% and 27% are CDS and UTR
sequences. Our results revealed a statistically significant bias
for exonization of new TE exons in the UTR, as compared
with CDS regions, for Alu, MIR, L1, and L2 in human and for
B1, MIR, B2, B4, L1, and L2 in mouse (for χ2 test P values, see
Additional data file 4). This UTR bias is probably related to
selection against exonization in the CDS.
How many transposed element exons potentially 
contribute to proteome diversity?
The majority of exonizations in our dataset inserted an in-
frame stop codon within the CDS (in 61% to 84% of the cases);
in 9% to 24% of the cases they caused a frame shift in the
reading frame. Therefore, between 81% and 93% of the exons
were potentially harmful because they produced a truncated
protein. Only a small fraction of between 7% and 19% did not
possess an in-frame stop codon and did not generate a frame
Table 5
The effects of exonization on human protein coding regions
RE A Alt. CDS B CDS C UTR D Stop E Frameshift F Functional
Alu 15 (1.5%) 650 (61.5%) 396 (37%) 399 (61%) 158 (24%) 93 (14%)
MIR 3 (2%) 100 (55%) 78 (43%) 84 (84%) 9 (9%) 7 (7%)
L1 4 (2%) 144 (66%) 71 (32%) 107 (74%) 21 (15%) 16 (11%)
L2 2 (2%) 66 (64%) 35 (34%) 50 (76%) 8 (12%) 8 (12%)
LTR 9 (6%) 76 (49%) 70 (45%) 46 (60%) 14 (19%) 16 (21%)
DNA 0 (0%) 77 (81%) 18 (19%) 53 (69%) 20 (26%) 4 (5%)
The first column shows the different examined transposed elements (TEs). Columns 2, 3, and 4 show the positions of TE exonization within the 
mRNA: creating an alternative coding sequence (CDS) start (Alt. CDS), exonization within the CDS, or exonization within the untranslated region 
(UTR). The relative percentages are given in parentheses. Columns 5, 6, and 7 show the effect of exonization within the CDS: exonizations that 
contain an in-frame stop codon (within the exon); exonizations that create a frameshift in the CDS but do not contain an in-frame stop codon; and 
functional exonizations (exons that do not possess an in-frame stop codon and do not cause frameshifts). The relative percentages within CDS are 
indicated in parentheses. The total number of TEs (100%) is found at the foot of the second column of Table 1. LTR, long terminal repeat; MIR, 
mammalian interspersed repeat; RE, retroelement.
Table 6
The effects of exonization on mouse protein coding regions
RE Alt. CDS CDS UTR Stop Frameshift Functional
B1 4 (3%) 87 (65%) 43 (32%) 67 (77%) 13 (15%) 7 (8%)
MIR 3 (11%) 9 (33%) 15 (56%) 5 (55%) 0 (0%) 4 (45%)
B2 4 (5%) 37 (46%) 40 (49%) 29 (78%) 3 (8%) 5 (14%)
B4 3 (5%) 39 (63%) 20 (32%) 30 (77%) 5 (13%) 4 (10%)
L1 3 (3%) 54 (53%) 45 (44%) 38 (70%) 6 (11%) 10 (19%)
L2 0 (0%) 3 (33%) 6 (66%) 1 (33%) 1 (33%) 1 (33%)
LTR 3 (4%) 38 (53%) 31 (43%) 29 (76%) 6 (16%) 3 (8%)
DNA 1 (1%) 4 (36%) 6 (67%) 3 (75%) 0 (0%) 1 (25%)
The first column shows the different examined transposed elements (TEs). Columns 2, 3, and 4 show the positions of TE exonization within the 
mRNA: creating an alternative coding sequence (CDS) start (Alt. CDS), exonization within the CDS, or exonization within the untranslated region 
(UTR). In parentheses, the relative percentages are given. Columns 5, 6, and 7 show the effect of exonization within the CDS: exonizations that 
contain an in-frame stop codon (within the exon); exonizations that create a frameshift in the CDS but do not contain an in-frame stop codon; and 
functional exonizations (exons that do not possess an in-frame stop codon and do not cause frameshifts). The relative percentages within CDS are 
indicated in parentheses. The total number of TEs (100%) is found at the foot of the second column of Table 2. LTR, long terminal repeat; MIR, 
mammalian interspersed repeat; RE, retroelement.R127.12 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. http://genomebiology.com/2007/8/6/R127
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shift, and thus potentially contributed a new function to an
existing protein (Tables 5 and 6, columns 5 to 7). When these
exons were searched against PROSITE [35,36], 54 out of the
93 Alu exons, three out of seven MIR exons, six out of 16 L1
exons, five out of 8 L2 exons, and none of 17 LTR and DNA
exons were found to add a new protein domain (Additional
data file 9). Overall, 68 exons out of 141 (48%) exhibited a hit
against a domain in PROSITE [36], reducing the number of
domain-contributing TE exonizations to 4.3% (in mouse, only
one hit against a domain in PROSITE was found). Thus, our
results show that a small fraction of relatively young exonized
TEs has the potential to contribute to protein functionality.
However, we cannot rule out the possibility that the TE exons
that do not add a new protein domain also contribute to pro-
teome complexity by inserting into an existing protein
domain. Such is the case for exon 8, which is an Alu exoniza-
tion within ADAR2; the Alu exonization that was inserted into
the deaminase domain creates a twofold difference in this
gene's specific editing activity [12].
Do new exons resulting from transposed element 
exonizations differ in their characteristics from 
conserved alternatively spliced cassette exons?
We next examined the characteristics of these new exons
resulting from TE exonization. Conserved alternatively
spliced exons are under selective forces different from those
in constitutively spliced exons [11,37]. These exons contain
weaker 5'ss (ΔG), are shorter than constitutively spliced
exons, and have a high inclusion level with respect to the new
Alu exons [3]. Therefore, we examined these characteristics
among the different exons that originated from TEs and com-
pared the findings with those for 596 and 44,732 alternatively
skipped exons and constitutive exons conserved between
human and mouse, respectively.
The TE exons have a low inclusion level, with an average of
19.17 ± 26.2% in human and 26.51 ± 31.8% in mouse, the
inclusion level of human TEs being significantly lower
(Mann-Whitney;  P  < 10-6;  F i g u r e  4 c ) .  B o t h  v a l u e s  a r e
significantly lower than the 64.39 ± 31.1% of conserved alter-
natively spliced exons (Mann-Whitney; P = 0 and P < 10-66,
respectively). The TE exons are, on average, 143.4 ± 118.4 bp
long in human and 133.6 ± 75.1 bp in mouse (Figure 4d). They
are therefore significantly longer than conserved alternative
exons, in which the average length is 97.7 ± 56.7 nucleotides
(Mann-Whitney; P < 10-38 and P = 0, respectively), and simi-
lar to conserved constitutive exons in which the average is
132.4 ± 49.9 nucleotides (Mann-Whitney; P = 0.7 and P = 0.8,
respectively). In addition, the TE exons have a very weak 5'ss,
relative to alternatively spliced exons in which the average
U1/5'ss strength (ΔG) is -4.87 ± 2.26 kcal/mol for human
exons and -4.88 ± 2.26 kcal/mol for mouse (Figure 4a). This
in turn is significantly weaker than the conserved alternative
exons, whose ΔG is -5.62 ± 1.9 kcal/mol (Mann-Whitney; P <
10-9  and  P  < 10-6, respectively). Conserved alternatively
spliced exons have already been shown to have a significantly
weaker U1/5'ss strength than constitutively spliced exons
[11]. In humans, the TE exons that originated from Alu have
the lowest inclusion level, the weakest 5'ss and the shortest
exons, as compared with all other exonized TEs. In addition,
exonized  Alus have low divergence from the consensus
sequence, meaning that not many mutations are needed for
their exonization. In contrast, the MIR exons have the strong-
est 5'ss in both human and mouse, the highest inclusion level,
and these exons are also the most diverged exons among
SINEs (with respect to the consensus sequence) in both
human and mouse (Figure 4b). The high inclusion level could
be explained by the fact that the MIR element has one major
5'ss (Figure 5c), that contains an almost canonical 5'ss
sequence (CTA/gtaagt). This is also consistent with the
finding that the MIR exons contribute the highest level of
constitutive exonization in both human and mouse (Figure 1a
[v]) and have a relatively high inclusion level (Figure 4c).
Discussion
The majority of transposed elements have a biased 
insertion in introns
Our analysis revealed that the majority of TEs reside in
intronic sequences, although introns comprise only 24% of
the human genome [1]. SINEs tend to be localized in GC-rich
regions, which reflect gene-rich areas [1]. The insertions into
introns presumably reflect selection against insertion of TEs
into protein coding exons and preferable retroposition into
transcribed regions. L1 is the only active autonomous non-
LTR retrotransposon in the human and mouse genome. In
contrast to SINE elements, L1 tends to reside within AT-rich
areas in both human and mouse [1,2]. It is assumed that L1
elements, as well as LTRs, with their larger size in open read-
ing frames and the presence of polyadenylation signals, may
be more deleterious within genes than smaller SINE elements
[38]. This hypothesis is supported by the bias toward inser-
tion in the antisense orientation of both L1 and LTR within
the human and mouse introns. Furthermore, L1 insertions
within human introns were shown to reduce gene expression
[39-41], and inactive LINE-1 can slow down transcription. In
agreement with this hypothesis, L1 in both human and mouse
has the lowest presence within introns. The older, nonactive
LINEs, L2, and CR1 (L3), and DNA repeats have the same
percentage of presence within introns as the shorter SINE
elements, probably because of their inactive state, which is
tolerated by gene-rich areas.
Do transposed element exons reflect splicing errors?
The large fraction of exons within our dataset for which there
is only one piece of supporting EST/cDNA evidence raises an
intriguing question as to whether these exons reflect tempo-
rary splicing mistakes. Probably, some of these exons are
indeed splicing errors, reflecting the low fidelity of the spli-
ceosome machinery [42,43]. Another explanation is that the
new exon added to a gene will first have a very weak splice sig-
nal, and therefore it will be included in only a small fractionhttp://genomebiology.com/2007/8/6/R127 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. R127.13
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of mRNA (approximately 10%). As a consequence, this addi-
tion is free to evolve; with time, positive selection can
strengthen its splice sites, resulting in an increase in its frac-
tion within the transcriptome [3,14,44]. Our findings are in
agreement with this hypothesis. The Alu elements with the
lowest inclusion level are the most recent insertions within
the human genome, and MIR elements with the highest inclu-
sion level are much older. These 'newcomers', the low inclu-
sion exons, are the sites for future possible exaptation and
fixation within the human transcriptome. Presumably, these
exons are subjected to selective pressures that determine
their future evolution in terms of improved recognition by the
splicing machinery, as well as protein fixation, or alterna-
tively complete loss [10]. Long evolutionary periods are
needed for successful exaptation events, and these new exons
are the potential raw materials for future evolution in human
and mouse [3,6,7,44].
Higher transposed element exonization levels in 
human due to Alu insertions
Most of the new exons are exonized from intronic sequences.
In rodents, these new alternatively spliced exons originated
Characteristics of the exonized TEs Figure 4
Characteristics of the exonized TEs. (a) The free energy resulting from the base pairing of the 5'ss with U1 snRNA (ΔG) for the indicated exonized 
transposed elements (TEs). 'const.' and 'alt.' indicate conserved human and mouse constitutively spliced and alternatively spliced exons, respectively. (b) 
The divergence in percentage from the consensus sequence. (c) The average inclusion level. (d) The average exon length.
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from unique intronic sequences [45]. However, in the human
genome most of those exons came from highly repeated
sequences (in which 40% are Alu exons) [44]. An explanation
for this discrepancy might be that the main source for these
differences is the higher level of Alu elements within human
introns, along with its extraordinary high level of exonization.
Why is it that Alu elements are so able to exonize? Both ele-
ments, Alu in human and B1 in mouse, have the same ances-
tral origin, namely the 7SL RNA, but they still differ
tremendously in their ability to exonize. This could be
explained by the Alu element being a dimer and B1 a mono-
mer. Therefore, looking at the Alu as a double B1, we would
expect twice as many exonizations of Alus as compared with
B1 elements. However, the exonization level of the Alu ele-
ment is almost three times higher than that of B1 (Fisher's
exact test [χ2] between a double amount of exonization of B1
and the Alu actual exonization level gives a statistically signif-
icant difference; P < 10-11). Thus, it seems that the dimeric
structure of Alu has a synergetic effect on alternative exoniza-
tion. Alu comprises two arms, with the right arm having an
addition of 31 nucleotides with respect to the left arm. B1 is
homologous to the left arm of the Alu. The majority of Alu
exonizations occur within the right arm; 959 of the exons are
found within the right arm, and only 24 are found within the
left arm. Both B1 and the left arm of the Alu have the same
highly selected 5'ss and 3'ss (Figure 5a,b). However, the right
arm of the Alu contains more potential splice sites (four 5'ss
and three 3'ss). This indicates that the Alu dimeric structure,
along with its unique left arm sequence that does not exist in
B1, are the main contributors to Alu's extraordinary ability to
exonize.
5' and 3' splice site selection of Alu, B1, and MIR Figure 5
5' and 3' splice site selection of Alu, B1, and MIR. Both Alu and B1 originated from 7SL RNA. Alu has a dimeric form with a very similar left and right arm, 
whereas B1 has a monomeric form similar to the left arm of the Alu element. (a) The most selected 5'ss and 3'ss within the exonized Alu element in the 
antisense orientation. The right and left arm are shown by boxes. The numbers within the boxes indicate positions (according to the Alu consensus 
sequence) in which the prevalent 3'ss and 5'ss are selected, above and below the boxes, respectively. Pictogram depiction of each splice site is shown, the 
consensus sequence of Alu is marked above the pictogram, and the number of times that the site was selected is shown below it. (b and c) Similar 
presentation as in panel a for the prevalent 5'ss and 3'ss selected in B1 and mammalian interspersed repeat (MIR) elements, respectively.
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Potential splice sites contributed by transposed 
elements
All TEs contribute many potential splice sites both in their
sense orientation and in their antisense orientation (for num-
bers, see Additional data file 11). All SINEs have substantially
more splice sites in their antisense orientation, accounting for
their preferential exonization in the antisense orientation. In
addition, all SINEs have a polyA tail at the end of their
sequences. This polyA tail becomes a polyT in the antisense
orientation. This sequence can later serve as a polypyrimidine
tract and facilitate exonization, as was previously shown for
Alu elements' 3'ss selection [4]. The 'AG' downstean of the
polyT is also the most selected 3'ss in all SINEs (as can be seen
for B1, Alu, and MIR in Figure 5).
Alu insertion gave rise to alternatively spliced human 
introns
The mechanism by which an insertion of a SINE element gave
rise to a new intron in the coding region of the catalase A gene
of rice was previously reported [21]. Here we show that this
mechanism is not limited to plants and is present in the
human genome also. Thus, the mechanism by which new
introns are generated by a SINE insertion also exists in the
human genome, leading to the conclusion that this intron
gain mechanism presumably is widespread outside plant
genomes as well. The new intron in rice is within the coding
sequence, but all four new introns reported here are within
the 3'-UTR. A noncanonical 3'ss is used by the intron created
within the CWF19L1; this intron is spliced at a 'tg' signal,
although there are two flanking 'ag' signals that could be used
as a canonical 3'ss. The use of a noncanonical 3'ss was previ-
ously reported [32]. We can also explain the use of the nonca-
nonical 3'ss by the possible secondary structure that is
created as a result of the presence of two Alus in close proxim-
ity and in opposite orientation, creating a presumably dsRNA
form, which may disrupt the correct splicing of this intron.
Evidence for the secondary structure is given by various A-I
editing sites that can be seen within these Alus. This structure
of two Alus in reverse orientation was shown to be the target
of editing [16]. Although such intronizations were not found
in mouse, we expect that in the metazoan such events are
more abundant within the UTRs than in the CDS, because
such events create a substantial rearrangement that have a
deleterious effect on the protein coding sequence. Previous
reports failed to detect intron gain within the mammalian
class [23,24], because these reports did not analyze alterna-
tively spliced introns and nonconserved regions within
human genes.
Transposed element exonization is a source of newly 
constitutively spliced exons
Our findings show that TE exonization mostly introduces a
low inclusion exon-skipping event (also see [3,44]).
Experimental analysis of selected exons has shown that TE
exonization can introduce a constitutively spliced exon within
the tested tissue and under the experimental conditions of the
RT-PCR experiments. This event can be the result of two pos-
sible scenarios: a newly constitutive exon either emerged in
one or in two steps, in which an alternative selection precedes
a constitutive one. The existence of many diseases created by
the introduction of a de novo Alu constitutive exonization,
along with a small number of mutations that were shown to
create a constitutively spliced Alu [11], supports the former
scenario. The significantly higher percentage of constitutively
spliced MIR (which is a more ancient TE within the human
genome) with respect to Alu (χ2; P < 0.003 [degrees of free-
dom = 1]) supports the latter option. Probably, these two sce-
narios reside side by side.
Our findings indicate that most of the exonizations generate
alternatively spliced exons. However, a small portion of the
exonizations generates constitutively spliced exons. The
question that arises is why new exons that are constitutively
spliced are not selected against? This is because they are
mostly found within the UTRs (71% versus 37% of TE exoni-
zations that are alternatively spliced), and when the exoniza-
tions occur within the CDS the exon lengths are mostly
'divisible-by-3', and therefore they do not interrupt the pro-
tein coding frame. In all other cases in which the exonizations
were constitutive and not symmetric, they were introduced
within hypothetical proteins. In these cases, these are either
not bona fide protein coding genes, or they are fast evolving
genes not bound to high selective pressure.
Alu and L1 act as pseudo-exons
We found that approximately 65% to 68% of the exonizations
originating from Alu, L1, and LTR are entirely contributed by
the Alu, L1, and LTR sequences, respectively, as compared
with approximately 40% contribution from all other TEs in
both human and mouse. These findings suggest that Alu, L1,
and LTR have the greatest potential for being recognized as
an exon without assistance from additional signals found ran-
domly within adjacent intronic sequences. This could explain
the reported interference with the selection of abnormal
splice sites caused by Alu  and L1 insertion within introns
(reviewed by [46]). The deleterious effect may be due to an
insertion of a competitive target for the spliceosome machin-
ery. We found about 750,000 intronic Alu elements, suggest-
ing that insertion into introns of Alus is generally tolerated.
However, several diseases caused by de novo Alu insertion
within introns have been reported [46]. This implies that ret-
ropositions into functionally important sequences within
introns, or Alu insertions that effect essential splicing activi-
ties, are selected against. Also, intronic Alus with a putative
polypyrimidine tract and a downstream potential 5'ss may
function as pseudo-exons that are not spliced, but compete
for the binding of splicing factors. Such competition may alter
mRNA splicing of the flanking exons, such as shifting the
splicing of the surrounding exons from constitutive to
alternative [46] (Lev-Maor G and coworkers, unpublished
data); 7,810 intronic pseudo-Alu exons were identified previ-
ously [5].R127.16 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. http://genomebiology.com/2007/8/6/R127
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Transposed element insertions in the first and last 
exons
The UTR contains motifs that can regulate many aspects of
mRNA function, such as nuclear export, cytoplasmatic locali-
zation, translational efficiency, and stability [47]. Moreover,
alternative UTRs were shown to determine tissue-specific
functions [48]. Our findings show that, on average, 3.5% and
7.6% of the first and last exons in the human genome contain
TEs, as compared with only 0.4% and 1.7% of first and last
exons in the mouse genome. These findings suggest a much
greater effect of TE insertions into the UTRs of the human
transcriptome as compared with the mouse transcriptome.
However, we found no biased insertion of TEs in the first or
last exon.
How many transposed elements contribute to 
proteome diversity?
Our findings suggest that the potential contribution of exons
originated from TEs to proteome complexity is very low. Only
4.3% of the exonized TEs potentially contributed a new func-
tionality to the proteome, which is consistent with previous
reports [3,7]. Gotea and Makalovski [7] argue that a long evo-
lutionary period is needed for a successful exaptation event,
and that it is unlikely that young TEs will contribute a new
function to a protein. Our results are in agreement with this
observation, indicating that although many insertion events
happened, the fraction of potential functional TE exons is low
(about 4%). However, the fraction of functional exonized TEs
may be even greater than that, because some of the exonized
TEs may affect other regulatory pathways, such as regulation
of mRNA level by activation of nonsense-mediated decay
(NMD), especially if the exon is in the 3' half of the gene [49-
51]. Other studies suggest that not all of the isoforms that con-
tain premature termination codon (PTC) are subject to
degradation by NMD [52], and NMD might only reduce the
amount of the PTC containing isoform [53]. Therefore, inser-
tion of PTC-containing exons could potentially be a source of
novel sequences that advance regulatory networks.
Do transposed element exonizations lead to tissue or 
cancer-specific isoforms?
We found 74 (< 8%) exons in the human and 18 (< 4%) exons
in the mouse genome that have a potential tissue-specific
association. In addition, six genes were found in which the
Alu  exonization was potentially specific to cancer. Two of
them, YY1AP and KUB3, were reported to be involved in
tumorogenesis [54-56].
Conclusion
Our results demonstrate the importance of TEs in shaping
both the human and the mouse transcriptomes in many dif-
ferent ways. However, the effect of TEs on the human tran-
scriptome is several times greater than the effect on the
mouse transcriptome, mostly because of the contribution of
the primate-specific Alu elements.
Materials and methods
Dataset of transposed element exons in human and 
mouse genomes
The human NCBI 35 (hg17; May 2004) and the mouse
NCBI33m (mm6; March 2005) assembly were downloaded,
along with their annotations, from the UCSC genome browser
database [28]. Coordinates of the EST and cDNA mapping
were obtained from chrN_intronEST and chrN_mrna tables,
respectively. TE mapping data were obtained from
chrN_rmsk tables. A TE was considered to be intragenic if
there was no overlap with ESTs or cDNA alignments; it was
considered intronic if it was found within an alignment of an
EST or cDNA in their intronic region. Finally, a TE was
considered exonic if it was found within an exonic part of the
EST or cDNA, if it possessed canonical splice sites, and if it
was not the first or last exon of the EST/cDNA.
The insertions of TEs within EST/cDNA alignments were sep-
arated into two parts: those that entered within protein cod-
ing genes relative to the list included in the knownGene table
in the UCSC genome browser [28] (based on proteins from
SWISS-PROT, TrEMBL, TrEMBL-NEW, and their corre-
sponding mRNA from GenBank), and other insertions within
cDNA/ESTs alignments that were not mapped to the known
genes list, and therefore were considered to be non-protein-
coding genes. Non-protein-coding genes were defined as
genomic regions covered by at least two correctly spliced
cDNA/ESTs (flanked by canonical splice sites) containing at
least three exons that did not overlap any annotated gene
based on UCSC known genes lists, versions hg17 and mm6 for
human and mouse, respectively. Unspliced genes were not
included in our analysis; we only considered genes with at
least two introns. Internal UTR exons were considered to be
internal based on the annotations of knownGenes in UCSC
and the fact that they were internal within the cDNA/EST.
The TE position within the gene (UTR or CDS) and the exon
phase were calculated based on the knownGenes table anno-
tations of the gene start and end positions, as well as CDS
start and end positions.
Splice site analysis was the same as that report by Sorek and
coworkers [5]. For TE analysis, we used RepeatMasker [57]
and Repbase annotations [58].
Analysis of retroelement insertions within the first and 
last exons and assessment of untranslated region 
fraction in known genes
The tables knownGenes and kgXref were used to assess the
relative lengths of the UTR and the CDS within 16,776 known
mouse genes and 19,480 known human genes, as well as to
find the first and last exons and to check for TE content. We
have found that the UTRs comprise 21% of human genes and
27% of mouse genes, respectively, and the CDSs comprise
79% of human genes and 73% of mouse genes, respectively.
These numbers served as the null hypothesis for comparison
with the fraction of exonizations within the UTR and the CDShttp://genomebiology.com/2007/8/6/R127 Genome Biology 2007,     Volume 8, Issue 6, Article R127       Sela et al. R127.17
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of all TEs. A goodness-of-fit χ2 test was used to asses the
exonization fraction in every section of the gene.
Statistical analysis
For the comparative analysis of exonization level, we used a
contingency table χ2 test. When the contingency table was a 2
× 2 table, the Fisher's exact test was used. To assess the ten-
dency of exonization within the UTR, we used the goodness-
of-fit χ2 test. The null hypothesis was the fraction of the UTR
and CDS within the known gene list of human and mouse (the
calculation of this fraction is explained above).
Calculation of exonization level and inclusion level
The definition of 'level of exonization' (LE) is the percentage
of TEs that exonized (NE) within the number of TE within
introns (NI):
The definition of 'inclusion level' (IL) is the number of tran-
scripts (cDNA/EST) that contain the exon (Nc) divided by the
sum of the transcripts that include the exon (Nc) and the
number of transcripts in which the exon is skipped (Ns).
Tissue classification of expressed sequence tags/cDNA 
and statistical analysis of tissue-specific and cancer-
specific exons
The tissue source and the cancer/normal source of each EST
were extracted from UniGene [59] or from GenBank annota-
tions. We used Bayesian statistics as proposed in [30,31]. The
criteria for high confidence of tissue specificity were TS > 50,
rTS > 0.9, and rTS~> 0.9 (for details see [30,31]). A necessary
condition for tissue specificity was at least three EST observa-
tions of the mRNA containing the exon in tissue T. For cancer
specificity, an LOD score was calculated; only LOD scores
above 2 (equivalent to P < 0.01) were considered to indicate
cancer specificity.
RT-PCR analysis of Alu and MIR exonization
All RNA was extracted from both the SH-SY5Y human cell
line and mouse brain tissue. RT-PCR was performed using
species-specific primers. Splicing products were separated on
1.5% agarose gel and confirmed by sequencing.
RT-PCR analysis of Alu intronization in CWF19L1 gene
The spliced cDNA products derived from commercial cDNAs
(BioChain) were detected by PCR, using endogenous forward
and reverse primers: forward (human), GAGGTCCT-
GGCCAGTGAAGCCA; reverse (human), GTACTTGGAGCT-
GGATAACAG; forward (mouse)
GAGGTCCTGGCCAGCGAAGCTA; and reverse (mouse)
GTTCTTAGAAATACATAGCAG. Amplification was
performed for 30 cycles, consisting of 1 min at 94°C, 45 s at
55°C, and 1.5 min at 72°C. The products were resolved on
1.5% agarose gel and confirmed by sequencing.
Analysis of potential splice sites
The consensus sequences of the most abundant TE family
from each TE class were analyzed for the existence of splice
sites in both the sense and antisense orientations. The 5'ss
was searched as 'gtnngn' or 'gcangn' (because these were
shown to be active splice sites [5]). The 3'ss was searched as
having at least 6 base pairs within its polypyrimidine tract
[60] and a nearby (a distance of 3 base pairs at most) 'ag'.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a table describ-
ing the number of exonizations based on the existence of two
ESTs/cDNA. Additional data file 2 is a table of all χ2 test P val-
ues of all TE exonization levels. Additional data file 3 is a table
of statistical χ2 test P values for the preference of all TE exoni-
zations in the sense/antisense orientation. Additional data
file 4 is a table of statistical χ2 test P values for the preference
of all TE exonizations in the UTR. Additional data file 5 is an
example of Alu  exonization within a non-protein-coding
gene. Additional data file 6 shows alignment of mouse L1
(Lx8) and human L1 (L1MC4). Additional data file 7 shows
the populations of different families of L1 within human and
mouse. Additional data file 8 is a table of cDNA and EST
accessions, confirming the noncanonical 3' splice site of the
alternative intron within CWF19L1 gene. Additional data file
9 is a table showing the domains contributed by TE exons.
Additional data file 10 is a table of tissue and cancer-specific
TEs. Additional data file 11 is a table of the potential splice
sites of all TEs. Additional data file 12 shows RT-PCR of
ACAD9 Alu exonization in different human cell lines. Addi-
tional data file 13 contains the coordinates of all tissue-spe-
cific and cancer specific exons in both human and mouse.
Additional data file 1 Number of exonizations based on the existence of two ESTs/cDNA Presented is a table describing the number of exonizations based on  the existence of two ESTs/cDNA. Click here for file Additional data file 2 χ2 test P values of all TE exonization levels Presented is a table of all χ2 test P values of all TE exonization  levels. Click here for file Additional data file 3 Statistical χ2 test P values for the preference of all TE exonizations  in the sense/antisense orientation Presented is a table of statistical χ2 test P values for the preference  of all TE exonizations in the sense/antisense orientation. Click here for file Additional data file 4 Statistical χ2 test P values for the preference of all TE exonizations  in the UTR Presented 4 is a table of statistical χ2 test P values for the preference  of all TE exonizations in the UTR. Click here for file Additional data file 5 An example of Alu exonization within a non-protein-coding gene Presented is an example of Alu exonization within a non-protein- coding gene. Click here for file Additional data file 6 Alignment of mouse L1 (Lx8) and human L1 (L1MC4) Presented is an illustration showing alignment of mouse L1 (Lx8)  and human L1 (L1MC4). Click here for file Additional data file 7 Populations of different families of L1 within human and mouse Presented is an illustration showing the populations of different  families of L1 within human and mouse. Click here for file Additional data file 8 cDNA and EST accessions, confirming the noncanonical 3' splice  site of the alternative intron within CWF19L1 gene Presented is a table of cDNA and EST accessions, confirming the  noncanonical 3' splice site of the alternative intron within  CWF19L1 gene. Click here for file Additional data file 9 Domains contributed by TE exons Presented is a table showing the domains contributed by TE exons. Click here for file Additional data file 10 Tissue and cancer-specific TEs Presented is a table of tissue and cancer-specific TEs. Click here for file Additional data file 11 Potential splice sites of all TEs Presented is a table of the potential splice sites of all TEs. Click here for file Additional data file 12 RT-PCR of ACAD9 Alu exonization in different human cell lines Presented is an illustration showing RT-PCR of ACAD9 Alu exoni- zation in different human cell lines. Click here for file Additional data file 13 Coordinates of all tissue-specific and cancer specific exons in both  human and mouse Presented is an Excel file containing coordinates of all tissue-spe- cific and cancer specific exons in both human and mouse. Click here for file
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